SCHEMBL30953263

SCHEMBL30953263

CC(C)(C)OC(=O)N[C@H](C(=O)Nc1cc(C=O)ccn1)C(C1CC1)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 5/20 0.39
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ ATR Q13535 1/20 0.34
▸ ACACB O00763 1/20 0.34
▸ ACACA Q13085 1/20 0.34
▸ EGFR P00533 2/20 0.34
▸ GSK3B P49841 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ CTSS P25774 1/20 0.33
▸ CTSK P43235 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27393638 0.84 AAK1 (0.48) AAK1KDM4EATRACACBACACA
SCHEMBL30953269 0.84 AAK1 (0.48) AAK1KDM4EATRACACBACACA
SCHEMBL30953236 0.84 CDK5 (0.40) AAK1ACACBACACADYRK1ACTSS
SCHEMBL30953311 0.80 AAK1 (0.44) AAK1KDM4EATRGSK3BTGFBR1
SCHEMBL30953345 0.79 AAK1 (0.36) AAK1ACACBACACADYRK1AMEN1
SCHEMBL1258539 0.79 ATR (0.47) AAK1ATRGSK3BDYRK1ATGFBR1
SCHEMBL30953342 0.78 AAK1 (0.38) AAK1ACACBACACAEGFRDYRK1A
SCHEMBL30953405 0.77 CYP3A4 (0.40) AAK1ACACBACACAEGFRGSK3B
SCHEMBL30953409 0.77 CYP3A4 (0.40) AAK1ACACBACACAEGFRGSK3B
SCHEMBL30953247 0.77 AAK1 (0.35) AAK1ACACBACACAEGFRCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback